| abstract |
The present invention provides a novel compound having good antibacterial activity against multidrug-resistant bacteria such as MRSA and VRE. Derivatives of the known thiopeptide compound QN3323-A modified at positions 2, 26, 33 and 48 have good antibacterial activity, especially against multidrug resistant bacteria such as MRSA and VRE. Excellent antibacterial activity. Therefore, it is useful as a preventive / therapeutic agent for pharmaceuticals, particularly antibacterial agents, especially multidrug resistant bacterial infections. [Selection figure] None |